We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Robotic Next Generation Sequencing Platform Accurately Screens Thousands of COVID-19 Samples at Once

By HospiMedica International staff writers
Posted on 04 Mar 2021
Image: Jeff Wrana, left, is seen in this undated file photo at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada (Photo courtesy of Sinai Health)
Image: Jeff Wrana, left, is seen in this undated file photo at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada (Photo courtesy of Sinai Health)
A robotics platform to screen thousands of COVID-19 samples at once has the potential to revolutionize how labs track the spread of viruses and other pathogens, according to new findings.

The study by researchers from the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health (Toronto, ON, Canada) found that their next-generation, ultra-high-throughput sequencing platform, called C19-SPAR-Se, has a sensitivity rate greater than 95% in positive cases during peak onset. The platform is also cost-effective. The study notes it only costs about USD 8 per test when running thousands of samples at once, as the cost per sample decreases due to economies of scale.

"Identifying positive samples quickly and accurately is critical in beating this pandemic," said Dr. Jeff Wrana, senior investigator at the LTRI and professor in the Department of Molecular Genetics at the University of Toronto. "With new and potentially dangerous variants now circulating, this is a platform that is scalable, automated and capable of analyzing thousands of COVID-19 patient samples in a single instrument run."

Related Links:
Lunenfeld-Tanenbaum Research Institute

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel

Channels

Medical Imaging

view channel
Image: A preclinical rabbit model undergoing longitudinal ocular vascular monitoring before and after induced optic nerve injury (upper panel) and a clinical cohort including patients with cervical lymph nodes of different pathological types (bottom panel) were used to demonstrate the generalizability of the framework. The experimental procedures for both studies include ultrasound data acquisition and reconstruction, extraction and analysis of vascular biomarkers, and construction of diagnostic models. The hierarchical edge-bundling diagram (right) illustrates relationships among ocular biomarkers. Each circular leaf node represents a specific biomarker measured in a particular vascular structure. Node size is proportional to the magnitude of the statistically significant difference observed for that biomarker in this study; larger nodes indicate a greater statistically significant difference. (Photo courtesy of XUEJUN Lab@ShanghaiTech)

Automated Platform Converts Super-Resolution Ultrasound into Vascular Biomarkers

Microvascular dysfunction, an early marker of glaucoma, cancer, and other systemic illnesses, often precedes overt clinical signs yet remains difficult to quantify deep in tissue. Super-resolution ultrasound... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more